Apollon Wealth Management LLC boosted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 12.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,317 shares of the company’s stock after buying an additional 2,746 shares during the quarter. Apollon Wealth Management LLC’s holdings in Colgate-Palmolive were worth $2,302,000 at the end of the most recent quarter.
A number of other large investors also recently bought and sold shares of the company. Chicago Partners Investment Group LLC raised its stake in Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after acquiring an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors boosted its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC bought a new position in Colgate-Palmolive during the 4th quarter worth $4,066,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
CL has been the subject of several analyst reports. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $101.16.
Colgate-Palmolive Stock Performance
CL opened at $86.81 on Monday. The business has a fifty day simple moving average of $90.36 and a 200-day simple moving average of $96.77. The firm has a market cap of $70.93 billion, a PE ratio of 24.66, a P/E/G ratio of 4.12 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the firm posted $0.87 EPS. As a group, equities analysts predict that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Volatility ETFs to Help You Profit from Market Chaos
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- What is the Nasdaq? Complete Overview with History
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.